Mice treated with an adenoviral vector to overexpress EcSOD in both melanoma and pancreatic tumors showed significantly decreased VEGF expression on immunohistochemistry and Western blot as well as decreased tumoral vessel density on hematoxylin and eosin and immunostaining [54,59]. This evidence concerns the gene VEGFA and pancreatic neoplasm.